Vycor Medical (VYCO) Accumulated Expenses (2010 - 2026)

Vycor Medical (VYCO) has 17 years of Accumulated Expenses data on file, last reported at $90953.0 in Q1 2026.

• On a quarterly basis, Accumulated Expenses fell 82.93% year-over-year to $90953.0 in Q1 2026; TTM through Mar 2026 was $90953.0, a 82.93% decrease from a year earlier, with the FY2025 full-year figure at $89938.0, down 42.91% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $90953.0, up from $89938.0 in the prior quarter.
• Over the last five years, Accumulated Expenses for VYCO reached as high as $544833.0 in Q2 2025 and fell as low as $89938.0 in Q4 2025.
• Historically, Accumulated Expenses has averaged $315972.2 across 5 years, with a median of $390599.0 in 2022.
• Across the five-year window, Accumulated Expenses surged 156.74% in 2025 and slumped 82.93% in 2026, its largest moves.
• Year by year, Accumulated Expenses stood at $146007.0 in 2022, then surged by 33.91% to $195522.0 in 2023, then decreased by 19.42% to $157545.0 in 2024, then slumped by 42.91% to $89938.0 in 2025, then grew by 1.13% to $90953.0 in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $90953.0 in Q1 2026, $89938.0 in Q4 2025, and $127231.0 in Q3 2025.